Milestone Scientific Inc. MLSS

Annual Quarterly

Q2 FY2026 · ended Jun 30, 2026 · Revenue $2.84M, +31.4% YoY · Filed Aug 13, 2026

Milestone Scientific Inc. (MLSS) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $2.8 million and a net loss of $1.1 million. Free cash flow was -$589,266. As of Jun 30, 2026 it held $2.1 million in cash and investments and $149,721 in total debt.

Revenue
$2.84M
+31.4% vs prior quarter
Net income
$-1.06M
-26.1% vs prior quarter
Operating cash flow
$-585,127
+66.8% vs year-ago quarter
Free cash flow
$-589,266
-791.5% vs prior quarter
EPS
$-0.01
+0.0% vs prior quarter
Dividend per share
None
Shares outstanding
88.74M
+13.0% vs year-ago quarter
Net cash
$1.92M
Q2 FY2026
Operating margin
-43.6%
TTM

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
MLSS (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Livingston, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
855683
Former names
MILESTONE SCIENTIFIC INC/NJ (until Dec 17, 2009); U S OPPORTUNITY SEARCH INC (until Mar 14, 1997)

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q4 FY2024
Dec 31, 2024
Revenue
$2.8M
$2.2M
$2.1M
$2.4M
$2.0M
Operating income
-$1.1M
-$828,083
-$1.1M
-$1.1M
-$2.0M
Net income
-$1.1M
-$839,853
-$1.1M
-$1.2M
-$2.0M
Diluted EPS
-$0.01
-$0.01
-$0.01
-$0.01
—
Operating cash flow
-$585,127
$86,842
-$226,129
$81,775
-$1.5M
Free cash flow
-$589,266
$85,210
-$229,245
$69,767
—
Total assets
$8.3M
$8.0M
$7.8M
$8.5M
$9.8M
Total liabilities
$4.9M
$5.7M
$5.0M
$5.9M
$4.0M
Stockholders' equity
$3.5M
$2.3M
$2.8M
$2.5M
$5.8M
Cash and investments
$2.1M
$1.2M
—
—
$0
Total debt
$149,721
$185,348
$219,043
$253,738
$349,054

Recent SEC filings

Form Description Filed Period
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Officer or director change, Shareholder vote results
 Jul 31, 2026 Jul 27, 2026
8-K Current report
Other events
 Jul 29, 2026 Jul 24, 2026
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure
 Jun 25, 2026 Apr 30, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Auditor change
 May 6, 2026 Apr 30, 2026

All 810 Milestone Scientific Inc. SEC filings

Source: SEC EDGAR filings. This is company-reported data, not investment advice.